Cold and flu season Temporada de influenza y resfriados

ALERT: Stay healthy this cold and flu season! Learn more

ALERTA: ¡Mantente sano durante esta temporada de influenza y resfriados! Más información

New Website! ¡Nuevo sitio web!

ALERT: We have made the Texas Children’s Health Plan website even easier to use! Click here to learn more.

ALERTA: ¡Ahora el sitio web de Texas Children’s Health Plan es aún más sencillo de usar! Haz clic aquí para más información.

Enfamil shortage updates Escasez de Enfamil Reguline

ALERT: Shortage of Enfamil products until October 31, 2024. Learn more.

ALERTA: Escasez de productos de Enfamil hasta el 31 de octubre de 2024. Más información.

Change Healthcare Incident Change Healthcare incidente

Search

HHSC to Remove Oxbryta Products from all Formularies as of Oct. 10, 2024

Date: October 4, 2024
Attention: Providers
Effective date: October 10, 2024

Call to action: On September 25, 2024, Pfizer, the manufacturer voluntarily recalled all Oxbryta® (voxelotor) products from worldwide markets due to safety concerns.

Oxbryta will no longer be a covered benefit and will no longer be on the formulary starting October 10, 2024. 

ProductNDC No.
OXBRYTA 500 MG TABLET72786010101
OXBRYTA 300 MG TABLET FOR SUSP72786011102
OXBRYTA 300 MG TABLET FOR SUSP72786011103
OXBRYTA 300 MG TABLET72786010202
OXBRYTA 300 MG TABLET72786010203

Next step for Providers: Providers should inform their impacted patients and arrange for the return and replacement of the drug.

If you have any questions, please email Provider Relations at: providerrelations@texaschildrens.org.

For access to all provider alerts,log into:
www.thecheckup.org or www.texaschildrenshealthplan.org/for-providers.